Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.German pharmaceutical company Bayer and Yunona Holdings, representing the Ural Pharmaceutical Cluster (UPC) of Russia have entered a memorandum of understanding to manufacture drugs in Russia.
Subscribe to our email newsletter
The companies intend to establish themselves in the fields of production, marketing and distribution of pharmaceutical products in Russia, inpharm.com reported.
The UPC which is a complex of interconnected production and infrastructure facilities is known to manufacture and sell medicines and medical equipment.
The cluster has received funds worth 27.3 bn roubles (around $860m) from Russia’s economic development programme between 2010 and 2015.